Zobair Younossi Selected Research

Zobair Younossi Research Topics

Disease

19	Fibrosis (Cirrhosis) 03/2024 - 07/2003
19	Non-alcoholic Fatty Liver Disease 01/2024 - 11/2009
14	Infections 01/2023 - 09/2003
13	Chronic Hepatitis C 01/2019 - 02/2002
8	Hepatitis C 09/2021 - 07/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2016
4	Liver Diseases (Liver Disease) 03/2024 - 09/2003
4	Fatigue 09/2022 - 03/2007
4	Anemia 06/2011 - 05/2004
3	Nausea 01/2024 - 05/2004
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 12/2019
3	End Stage Liver Disease 01/2022 - 02/2004
3	Chronic Disease (Chronic Diseases) 06/2021 - 12/2004
3	Alcoholic Fatty Liver 01/2020 - 12/2015
2	COVID-19 02/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 05/2022 - 12/2015
2	Neutropenia 05/2013 - 06/2011
2	Headache (Headaches) 05/2013 - 05/2004
1	Diarrhea 01/2024
1	Alcoholism (Alcohol Abuse) 01/2023
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Obesity 05/2022
1	Weight Loss (Weight Reduction) 05/2022
1	Heart Failure 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Unstable Angina 01/2022
1	Myocardial Infarction 01/2022
1	Inflammation (Inflammations) 01/2020
1	Cicatrix (Scar) 01/2020
1	Disease Progression 12/2019
1	Cryptogenic Cirrhosis 12/2018
1	Chronic Hepatitis B 07/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Coinfection 08/2015
1	Bradycardia 08/2015
1	Fatty Liver 02/2015
1	Overweight 02/2015
1	Insulin Resistance 12/2013
1	Hyperlipidemias (Hyperlipidemia) 07/2013
1	Hypertension (High Blood Pressure) 07/2013

Drug/Important Bio-Agent (IBA)

11	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 02/2002
9	Antiviral Agents (Antivirals)IBA 02/2023 - 09/2003
5	InterferonsIBA 01/2019 - 02/2002
5	SofosbuvirIBA 01/2017 - 05/2013
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2013
3	CollagenIBA 12/2019 - 10/2018
3	Alanine Transaminase (SGPT)IBA 07/2017 - 12/2013
3	Triglycerides (Triacylglycerol)IBA 02/2015 - 07/2003
3	Epoetin Alfa (Epogen)FDA Link 01/2005 - 05/2004
2	resmetiromIBA 01/2024 - 06/2019
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2018
2	obeticholic acidIBA 01/2022 - 01/2019
2	simtuzumabIBA 12/2019 - 10/2018
2	ledipasvirIBA 12/2016 - 08/2015
2	daclatasvirIBA 02/2016 - 05/2015
2	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 02/2016 - 05/2015
2	asunaprevirIBA 02/2016 - 05/2015
2	MicroRNAs (MicroRNA)IBA 01/2016 - 04/2015
2	telaprevirIBA 12/2013 - 06/2011
2	peginterferon alfa-2a (Pegasys)FDA Link 05/2013 - 06/2011
2	Interferon-alpha (Interferon Alfa)IBA 12/2004 - 05/2004
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2024
1	AntigensIBA 01/2023
1	AntibodiesIBA 01/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2022
1	Pioglitazone (Actos)FDA Link 05/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	selonsertibIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	nasIBA 12/2019
1	Monoclonal AntibodiesIBA 10/2018
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 10/2018
1	Receptor for Advanced Glycation End ProductsIBA 01/2018
1	Viral DNAIBA 07/2017
1	sofosbuvir drug combination ledipasvirIBA 02/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2016
1	Phospholipases (Phospholipase)IBA 01/2016
1	Amiodarone (Amiodarona)FDA LinkGeneric 08/2015
1	AdipokinesIBA 04/2015
1	Insulin (Novolin)FDA Link 02/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2013
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	NucleotidesIBA 05/2013
1	Phosphotransferases (Kinase)IBA 01/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2003
8	Liver Transplantation 01/2022 - 02/2004
3	Aftercare (After-Treatment) 01/2023 - 03/2017
3	Bariatric Surgery 05/2022 - 05/2010
2	Drug Tapering 03/2007 - 05/2004
1	Toothbrushing 01/2023
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023
1	Oral Hygiene (Dental Hygiene) 01/2023
1	Activities of Daily Living (ADL) 09/2022
1	Percutaneous Coronary Intervention 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Intravenous Infusions 10/2018
1	Subcutaneous Injections 10/2018
1	Transplantation 09/2014